Hutchison China MediTech (HCM) Reports 1st-Half Loss of $0.19

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Hutchison China MediTech (HCM) Reports 1st-Half Loss of $0.19

HUTCHMED Reports 2022 Interim Results and Provides Business Updates

August 1, 2022 7:00 AM EDT

Oncology/Immunology revenues up 113% to $91.1 million, due to ELUNATE®, SULANDA® and ORPATHYS® growth

First presentation of SAVANNAH data showing 52% response rate and 9.6 month duration of response in 2L+ post-TAGRISSO® NSCLC1 patients with high MET2 levels and no prior chemotherapy

Initiated six new trials thus far in 2022 with a further six starting, including with five new drug candidates

FRESCO-2 Phase III, our first global... More